“Joining the Spots in Adults and Young Tots”: A Clinicopathological Study of Henoch–Schönlein Purpura (IgA Vasculitis)

Introduction: Henoch–Schönlein Purpura (HSP; IgA vasculitis), the most common vasculitis of childhood, has a wide spectrum of clinical manifestations ranging from palpable purpura with abdominal pain and arthritis to the more morbid renal involvement. Aims and Objectives: To study and correlate the clinical presentation, laboratory values, skin and renal histopathology and immunofluoroscence findings in HSP. Material and Methods: A total of 44 cases of HSP from March 2011 to February 2014 were studied for the above features along with their clinical outcomes. Results: The mean age of the patients at presentation was 28.4 years (range 4.5–69 years) with 26.2% being children younger than 15 years. Purpura at presentation was seen in all with 77.1% cases exhibiting extracutaneous involvement. Skin biopsy revealed leukocytoclastic vasculitis in all cases, dominant IgA deposition in the papillary dermal vessels in 43 cases (97.7%), associated C3 in 10 cases (23.3%), and full-house positivity in 1 case. One case without skin immunofluorescence had renal mesangial IgA deposits. Nine cases (20.9%) with an average age of 39 years had renal symptoms and displayed varied histology from focal mesangioproliferative glomerulonephritis to crescentic. All of them had dominant mesangial IgA deposits, majority falling into International Study of Kidney Disease in Children (ISKDC) class IIIb. Peritubular capillaritis was noted in 3 cases. Two patients (4.5%) progressed to end stage renal disease, one of whom had cellular crescents at presentation. Conclusions: HSP was seen both in children and adults. Renal involvement was seen in 20.9% cases, all older than 14 years, and 66.7% with extracutaneous manifestations. The outcome in this series was favorable in 96% cases.

[1]  C. Lohse,et al.  Henoch–Schönlein purpura and systemic disease in children: retrospective study of clinical findings, histopathology and direct immunofluorescence in 34 paediatric patients , 2015, The British journal of dermatology.

[2]  M. González-Gay,et al.  Henoch-Schönlein Purpura in Northern Spain , 2014, Medicine.

[3]  M. Camilleri,et al.  Histopathology and correlates of systemic disease in adult Henoch-Schönlein purpura: a retrospective study of microscopic and clinical findings in 68 patients at Mayo Clinic. , 2013, Journal of the American Academy of Dermatology.

[4]  M. Hosoya,et al.  Henoch-Schönlein purpura nephritis in childhood: pathogenesis, prognostic factors and treatment. , 2013, Fukushima journal of medical science.

[5]  A. Nickavar,et al.  Clinicopathologic correlations in Henoch-Schonlein nephritis. , 2012, Iranian journal of kidney diseases.

[6]  Y. Tabel,et al.  Clinical features of children with Henoch-Schonlein purpura: risk factors associated with renal involvement. , 2012, Iranian journal of kidney diseases.

[7]  D. Chi,et al.  The clinical implications of adult-onset henoch-schonelin purpura , 2011, Clinical and molecular allergy : CMA.

[8]  T. Kawakami,et al.  IgM in lesional skin of adults with Henoch-Schönlein purpura is an indication of renal involvement. , 2010, Journal of the American Academy of Dermatology.

[9]  N. Sankhyan,et al.  A five year review of clinical profile in HSP. , 2007, JNMA; journal of the Nepal Medical Association.

[10]  J. H. Kim,et al.  Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch–Schönlein purpura , 2006, Scandinavian journal of rheumatology.

[11]  Yao-Hsu Yang,et al.  Renal manifestations in Henoch–Schönlein purpura: a 10-year clinical study , 2005, Pediatric Nephrology.

[12]  S. Mrusek,et al.  Henoch-Schönlein purpura , 2004, The Lancet.

[13]  M. Candelli,et al.  Predictive factors of renal involvement or relapsing disease in children with Henoch-Schönlein purpura , 2004, Rheumatology International.

[14]  Y. Kawasaki,et al.  Clinical and pathological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosis. , 2003, Clinical nephrology.

[15]  M. González-Gay,et al.  Henoch-Schönlein purpura in children and adults: clinical differences in a defined population. , 2002, Seminars in arthritis and rheumatism.

[16]  Y. Ogawa,et al.  Risk factors of renal involvement and significant proteinuria in Henoch-Schönlein purpura , 2002, European Journal of Pediatrics.

[17]  A. Bagai,et al.  Evaluation and therapeutic outcome of palpable purpura. , 2001, Indian journal of dermatology, venereology and leprology.

[18]  J. Llorca,et al.  Henoch-Schönlein Purpura in Children from Northwestern Spain: A 20-Year Epidemiologic and Clinical Study , 2001, Medicine.

[19]  J. Llorca,et al.  Predictive factors for renal sequelae in adults with Henoch-Schönlein purpura. , 2001, The Journal of rheumatology.

[20]  I. Uthman,et al.  Henoch-Schönlein purpura in adulthood and childhood: comment on the article by Blanco et al. , 1998, Arthritis and rheumatism.

[21]  J. Goraya,et al.  Henoch-Schonlein purpura: the Chandigarh experience. , 1998, Indian pediatrics.

[22]  V. Rodríguez-Valverde,et al.  Henoch-Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome. , 1997, Arthritis and rheumatism.

[23]  M. Rybojad,et al.  Schönlein-Henoch purpura in adult patients. Predictive factors for IgA glomerulonephritis in a retrospective study of 57 cases. , 1997, Archives of dermatology.

[24]  M. Stenbeck,et al.  Urinary tract. , 1995, Acta oncologica.

[25]  S. Kabra,et al.  Henoch-Schonlein syndrome in northern Indian children. , 1991, Indian pediatrics.